Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097981
Status:
COMPLETED
Last Update Posted:
2017-04-07
First Post:
2004-12-01
Brief Title:
A Study of Thalidomide Plus Dexamethasone Thal-Dex Versus DOXIL plusThalidomide Plus Dexamethasone DOXIL -Thal-Dex in Patients With Newly Diagnosed Multiple Myeloma
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC